{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T14:35:58Z","timestamp":1793802958521,"version":"4.6.1"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain Research"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1016\/j.brainres.2018.03.016","type":"journal-article","created":{"date-parts":[[2018,3,16]],"date-time":"2018-03-16T20:45:11Z","timestamp":1521233111000},"page":"1-7","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"special_numbering":"C","title":["NLX-112, a highly selective 5-HT 1A  receptor agonist, mediates analgesia and antidepressant-like activity in rats via spinal cord and prefrontal cortex 5-HT 1A  receptors, respectively"],"prefix":"10.1016","volume":"1688","author":[{"given":"A.","family":"Newman-Tancredi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Bardin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Auclair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Colpaert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Depoort\u00e8re","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.A.","family":"Varney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.brainres.2018.03.016_b0005","doi-asserted-by":"crossref","first-page":"199","DOI":"10.3389\/fnbeh.2014.00199","article-title":"Serotonin-prefrontal cortical circuitry in anxiety and depression phenotypes: pivotal role of pre- and post-synaptic 5-HT1A receptor expression","volume":"8","author":"Albert","year":"2014","journal-title":"Front. Behav. Neurosci."},{"key":"10.1016\/j.brainres.2018.03.016_b0010","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.brainres.2015.06.043","article-title":"Role of spinal 5-HT5A, and 5-HT1A\/1B\/1D, receptors in neuropathic pain induced by spinal nerve ligation in rats","volume":"1622","author":"Avila-Rojas","year":"2015","journal-title":"Brain Res."},{"issue":"2","key":"10.1016\/j.brainres.2018.03.016_b9000","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0014-2999(01)01029-9","article-title":"In the formalin model of tonic nociceptive pain, 8-OH-DPAT produces 5-HT1A receptor-mediated, behaviorally specific analgesia","volume":"421","author":"Bardin","year":"2001","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.brainres.2018.03.016_b0015","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1159\/000068404","article-title":"Profound, non-opioid analgesia produced by the high-efficacy 5-HT(1A) agonist F 13640 in the formalin model of tonic nociceptive pain","volume":"67","author":"Bardin","year":"2003","journal-title":"Pharmacology"},{"key":"10.1016\/j.brainres.2018.03.016_b0020","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.ejpain.2003.09.002","article-title":"Role of spinal 5-HT(1A) receptors in morphine analgesia and tolerance in rats","volume":"8","author":"Bardin","year":"2004","journal-title":"Eur. J. Pain"},{"key":"10.1016\/j.brainres.2018.03.016_b0025","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.ejphar.2005.03.016","article-title":"Effects of the high-efficacy 5-HT1A receptor agonist, F 13640 in the formalin pain model: a c-Fos study","volume":"514","author":"Buritova","year":"2005","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.brainres.2018.03.016_b0030","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1159\/000435931","article-title":"Neuroinflammatory mechanisms linking pain and depression","volume":"30","author":"Burke","year":"2015","journal-title":"Mod. Trend. Pharmacopsychiat."},{"key":"10.1016\/j.brainres.2018.03.016_b0035","first-page":"252","article-title":"The therapeutic role of 5-HT1A and 5-HT2A receptors in depression","volume":"29","author":"Celada","year":"2004","journal-title":"J. Psychiat. Neurosci."},{"key":"10.1016\/j.brainres.2018.03.016_b0040","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1007\/s40263-013-0071-0","article-title":"Serotonin 5-HT1A receptors as targets for agents to treat psychiatric disorders: rationale and current status of research","volume":"27","author":"Celada","year":"2013","journal-title":"CNS Drugs"},{"key":"10.1016\/j.brainres.2018.03.016_b0045","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/0014-2999(87)90523-1","article-title":"Potential antidepressant properties of 8-hydroxy-2-(di-n-propylamino)tetralin, a selective serotonin1A receptor agonist","volume":"144","author":"Cervo","year":"1987","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.brainres.2018.03.016_b0050","doi-asserted-by":"crossref","first-page":"18474","DOI":"10.3390\/ijms160818474","article-title":"Functional selectivity and antidepressant activity of serotonin 1A receptor ligands","volume":"16","author":"Chilmonczyk","year":"2015","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.brainres.2018.03.016_b0055","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/S0028-3908(02)00119-3","article-title":"Large-amplitude 5-HT1A receptor activation: a new mechanism of profound, central analgesia","volume":"43","author":"Colpaert","year":"2002","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.brainres.2018.03.016_b0060","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/0304-3940(87)90218-7","article-title":"Autoradiographic evidence of serotonin1 binding sites on primary afferent fibres in the dorsal horn of the rat spinal cord","volume":"83","author":"Daval","year":"1987","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.brainres.2018.03.016_b0065","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0014-2999(02)02640-7","article-title":"The 5-HT(1A) receptor agonist F 13640 attenuates mechanical allodynia in a rat model of trigeminal neuropathic pain","volume":"456","author":"Deseure","year":"2002","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.brainres.2018.03.016_b0070","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.ejpain.2004.01.002","article-title":"Effects of the combined continuous administration of morphine and the high-efficacy 5-HT1A agonist, F 13640 in a rat model of trigeminal neuropathic pain","volume":"8","author":"Deseure","year":"2004","journal-title":"Eur. J. Pain."},{"key":"10.1016\/j.brainres.2018.03.016_b0075","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.jpain.2012.03.009","article-title":"The economic costs of pain in the United States","volume":"13","author":"Gaskin","year":"2012","journal-title":"J. Pain."},{"key":"10.1016\/j.brainres.2018.03.016_b0080","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/0006-3223(88)90034-0","article-title":"Reversal of helpless behavior in rats by putative 5-HT1A agonists","volume":"23","author":"Giral","year":"1988","journal-title":"Biol. Psychiat."},{"key":"10.1016\/j.brainres.2018.03.016_b0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2015.05.021","article-title":"NLX-112, a novel 5-HT1A receptor agonist for the treatment of L-DOPA-induced dyskinesia: behavioral and neurochemical profile in rat","author":"Iderberg","year":"2015","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.brainres.2018.03.016_b0090","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1111\/j.1476-5381.2011.01685.x","article-title":"Role of 5-HT(1) receptor subtypes in the modulation of pain and synaptic transmission in rat spinal superficial dorsal horn","volume":"165","author":"Jeong","year":"2012","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.brainres.2018.03.016_b0095","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0006-3223(01)01216-1","article-title":"Regional cerebral glucose utilization in patients with a range of severities of unipolar depression","volume":"51","author":"Kimbrell","year":"2002","journal-title":"Biol. Psychiat."},{"key":"10.1016\/j.brainres.2018.03.016_b0100","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.ejphar.2005.09.003","article-title":"The novel analgesic, F 13640, produces intra- and postoperative analgesia in a rat model of surgical pain","volume":"523","author":"Kiss","year":"2005","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.brainres.2018.03.016_b0105","doi-asserted-by":"crossref","first-page":"e43221","DOI":"10.1371\/journal.pone.0043221","article-title":"Serotonin-1A receptor polymorphism (rs6295) associated with thermal pain perception","volume":"7","author":"Lindstedt","year":"2012","journal-title":"PloS One"},{"key":"10.1016\/j.brainres.2018.03.016_b0110","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1111\/j.1476-5381.1993.tb12859.x","article-title":"Mediation of the antidepressant-like effect of 8-OH-DPAT in mice by postsynaptic 5-HT1A receptors","volume":"108","author":"Luscombe","year":"1993","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.brainres.2018.03.016_b0115","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/1056-8719(94)90087-6","article-title":"A method to perform direct transcutaneous intrathecal injection in rats","volume":"32","author":"Mestre","year":"1994","journal-title":"J. Pharmacol. Toxicol. Method."},{"key":"10.1016\/j.brainres.2018.03.016_b0120","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/sj.npp.1300354","article-title":"Diabetes attenuates the antidepressant-like effect mediated by the activation of 5-HT1A receptor in the mouse tail suspension test","volume":"29","author":"Miyata","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.brainres.2018.03.016_b0125","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1097\/00001756-199212000-00007","article-title":"The role of 5-HT1A and 5-HT1B receptors in spinal nociceptive transmission and in the modulation of NMDA induced behaviour","volume":"3","author":"Mjellem","year":"1992","journal-title":"Neuroreport"},{"key":"10.1016\/j.brainres.2018.03.016_b0130","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1002\/nau.20037","article-title":"1-(2-pyrimidinyl)-piperazine, a buspirone metabolite, modulates bladder function in the anesthetized rat","volume":"23","author":"Myers","year":"2004","journal-title":"Neurourol. Urodynam."},{"key":"10.1016\/j.brainres.2018.03.016_b0135","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1007\/s00210-003-0788-2","article-title":"Comparison of hippocampal G protein activation by 5-HT(1A) receptor agonists and the atypical antipsychotics clozapine and S16924","volume":"368","author":"Newman-Tancredi","year":"2003","journal-title":"Naunyn-Schmiedeberg's Arch. Pharmacol."},{"key":"10.1016\/j.brainres.2018.03.016_b0140","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1111\/jphp.12762","article-title":"Distinctive in vitro signal transduction profile of NLX-112, a potent and efficacious serotonin 5-HT1A receptor agonist","volume":"69","author":"Newman-Tancredi","year":"2017","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.brainres.2018.03.016_b0145","series-title":"The Rat Brain in Stereotaxic Coordinates","author":"Paxinos","year":"2007"},{"key":"10.1016\/j.brainres.2018.03.016_b0150","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0006-3223(85)90194-5","article-title":"Selective interaction of novel anxiolytics with 5-hydroxytryptamine1A receptors","volume":"20","author":"Peroutka","year":"1985","journal-title":"Biol. psychiat."},{"key":"10.1016\/j.brainres.2018.03.016_b0155","doi-asserted-by":"crossref","first-page":"e218","DOI":"10.1038\/cddis.2011.98","article-title":"Anatomical study of serotonergic innervation and 5-HT(1A) receptor in the human spinal cord","volume":"2","author":"Perrin","year":"2011","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.brainres.2018.03.016_b0160","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.bbr.2014.12.052","article-title":"Bidirectional amygdaloid control of neuropathic hypersensitivity mediated by descending serotonergic pathways acting on spinal 5-HT3 and 5-HT1A receptors","volume":"282","author":"Sagalajev","year":"2015","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.brainres.2018.03.016_b0165","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.neuropharm.2017.07.022","article-title":"Antinociceptive, antiallodynic and antihyperalgesic effects of the 5-HT1A receptor selective agonist, NLX-112 in mouse models of pain","volume":"125","author":"Salat","year":"2017","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.brainres.2018.03.016_b0170","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.bbr.2016.01.033","article-title":"Antidepressant-like effect of cannabidiol injection into the ventral medial prefrontal cortex-Possible involvement of 5-HT1A and CB1 receptors","volume":"303","author":"Sartim","year":"2016","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.brainres.2018.03.016_b0175","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/0304-3959(92)90003-T","article-title":"The formalin test: an evaluation of the method","volume":"51","author":"Tjolsen","year":"1992","journal-title":"Pain"},{"key":"10.1016\/j.brainres.2018.03.016_b0180","first-page":"2547","article-title":"Mechanism of action of the bimodal antidepressant vilazodone: evidence for serotonin1A-receptor-mediated auto-augmentation of extracellular serotonin output","volume":"231","author":"van Amsterdam","year":"2014","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.brainres.2018.03.016_b0185","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1124\/dmd.107.015768","article-title":"6-Hydroxybuspirone is a major active metabolite of buspirone: assessment of pharmacokinetics and 5-hydroxytryptamine1A receptor occupancy in rats","volume":"35","author":"Wong","year":"2007","journal-title":"Drug. Metab. Dispos."},{"key":"10.1016\/j.brainres.2018.03.016_b0190","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.ejphar.2003.08.047","article-title":"The very-high-efficacy 5-HT1A receptor agonist, F 13640, preempts the development of allodynia-like behaviors in rats with spinal cord injury","volume":"478","author":"Wu","year":"2003","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.brainres.2018.03.016_b0195","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.expneurol.2004.08.031","article-title":"The novel analgesic and high-efficacy 5-HT1A receptor agonist F 13640 inhibits nociceptive responses, wind-up, and after-discharges in spinal neurons and withdrawal reflexes","volume":"191","author":"You","year":"2005","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.brainres.2018.03.016_b0200","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1124\/jpet.102.036798","article-title":"Pharmacokinetic-pharmacodynamic modeling of buspirone and its metabolite 1-(2-pyrimidinyl)-piperazine in rats","volume":"303","author":"Zuideveld","year":"2002","journal-title":"J. Pharmacol. Exp. Therap."}],"container-title":["Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006899318301513?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006899318301513?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,7,10]],"date-time":"2018-07-10T08:54:51Z","timestamp":1531212891000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006899318301513"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":41,"alternative-id":["S0006899318301513"],"URL":"https:\/\/doi.org\/10.1016\/j.brainres.2018.03.016","relation":{},"ISSN":["0006-8993"],"issn-type":[{"value":"0006-8993","type":"print"}],"subject":[],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"NLX-112, a highly selective 5-HT1A receptor agonist, mediates analgesia and antidepressant-like activity in rats via spinal cord and prefrontal cortex 5-HT1A receptors, respectively","name":"articletitle","label":"Article Title"},{"value":"Brain Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.brainres.2018.03.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}